LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 93.96 | 27.76 | 726 | 6849 | 0.1060 | 0.5079 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 93.96 | 27.76 | 1203 | 6849 | 0.1756 | 0.6069 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 93.96 | 27.76 | 770 | 6849 | 0.1124 | 0.5191 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 93.96 | 27.76 | 1393 | 6849 | 0.2034 | 0.6368 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 95.66 | 27.76 | 603 | 6712 | 0.0898 | 0.4752 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 95.66 | 27.76 | 1183 | 6712 | 0.1762 | 0.6063 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 95.66 | 27.76 | 687 | 6712 | 0.1023 | 0.4997 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 95.66 | 27.76 | 1407 | 6712 | 0.2096 | 0.6418 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 1.95 | 27.76 | 537 | 225 | 2.3852 | 1.6671 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 1.95 | 27.76 | 589 | 225 | 2.6161 | 1.7500 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 3.66 | 27.76 | 603 | 283 | 2.1238 | 1.5035 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 3.66 | 27.76 | 648 | 283 | 2.2823 | 1.5578 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 5.36 | 27.76 | 656 | 320 | 2.0477 | 1.4504 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 5.36 | 27.76 | 713 | 320 | 2.2256 | 1.5090 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 7.06 | 27.76 | 735 | 360 | 2.0417 | 1.4259 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 7.06 | 27.76 | 820 | 360 | 2.2778 | 1.4988 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | D06 |